Investigation of the effect of silymarin on the liver in experimental sepsis

被引:0
|
作者
Cihan, Burcu [1 ]
Yarat, Aysen [1 ]
Akbay, Tugba Tunali [1 ]
Sener, Goksel [2 ]
机构
[1] Marmara Univ, Fac Dent, Dept Biochem, TR-34365 Istanbul, Turkey
[2] Marmara Univ, Fac Pharm, Dept Pharmacol, TR-34365 Istanbul, Turkey
关键词
Sepsis; Silymarin; Liver; Tissue factor; Oxidative stress;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study is to investigate the possible protective effect of silymarin (extract of Silybum marianum) on the liver of septic rats was at early stage of sepsis. Polymicrobial sepsis was induced by the cecal ligation and perforation (CLP) technique. Sepsis and sepsis + silymarin treated groups received vehicle or silymarin (50 mg/kg, orally). The rats were decapitated 6 h after the CLP procedure. Protein, glutathione, lipid peroxidation levels, tissue factor activity and some enzyme activities were determined and polyacrylamid gel electrophoresis was carried on liver samples. TNF-a, IL-1b and IL-6 were determined in blood samples. Glutathione levels significantly increased and tissue factor activity significantly decreased in both sepsis and sepsis+silymarin treated groups when compared with control. Superoxide dismutase activity significantly decreased in sepsis+silymarin treated group when compared control and sepsis groups. No significant difference was found in electrophoresis protein bands. Blood proinflammatory cytokine levels were significantly decreased in silymarin treated sepsis group when compared with sepsis group. The effect of silymarin was not apparent since oxidative damage was not obvious in liver consequently it can be suggested that some protective mechanisms related with glutathione in liver may be involved in early stage sepsis.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 50 条
  • [31] Improved anti-inflammatory effect of Silymarin in rats induced liver carcinogenesis
    Alkaladi, Ali
    Abdelazim, Aser Mohamed
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (04): : 2865 - 2869
  • [32] Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice
    Wu, Yi-Fang
    Fu, Shu-Ling
    Kao, Cheng-Heng
    Yang, Chu-Wen
    Lin, Chao-Hsiung
    Hsu, Ming-Ta
    Tsai, Ting-Fen
    CANCER RESEARCH, 2008, 68 (06) : 2033 - 2042
  • [33] The effect of silymarin on liver enzymes in patients taking isotretinoin: A randomized clinical trial
    Mirnezami, Mina
    Jafarimanesh, Hadi
    Rezagholizamenjany, Masoud
    Alimoradian, Abbas
    Ranjbaran, Mehdi
    DERMATOLOGIC THERAPY, 2020, 33 (02)
  • [34] Is silymarin hepatoprotective in alcoholic liver disease?
    Berger, J
    Kowdley, KV
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (04) : 278 - 279
  • [35] CYTOPROTECTIVE EFFECT OF SILYMARIN AND PURPUROGALLIN ON HUMAN SKIN AND LIVER-CELLS INVITRO
    SHEAR, NH
    MALKIEWICZ, I
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 594 - 594
  • [36] The use of silymarin in the treatment of liver diseases
    Saller, R
    Meier, R
    Brignoli, R
    DRUGS, 2001, 61 (14) : 2035 - 2063
  • [37] CYTOPROTECTIVE EFFECT OF SILYMARIN AND PURPUROGALLIN ON HUMAN SKIN AND LIVER-CELLS INVITRO
    SHEAR, NH
    MALKIEWICZ, I
    CLINICAL RESEARCH, 1993, 41 (02): : A498 - A498
  • [38] Hepatoprotective effect of silymarin
    Vargas-Mendoza, Nancy
    Madrigal-Santillan, Eduardo
    Morales-Gonzalez, Angel
    Esquivel-Soto, Jaime
    Esquivel-Chirino, Cesar
    Garcia-Luna y Gonzalez-Rubio, Manuel
    Gayosso-de-Lucio, Juan A.
    Morales-Gonzalez, Jose A.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (03) : 144 - 149
  • [39] ANTIOXIDATIVE EFFECT OF SILYMARIN
    Cvejic, J.
    Raskovic, A.
    Mikov, M.
    Stilinovic, N.
    Sederino, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 88 - 88
  • [40] INVESTIGATION OF DISSOLUTION AND BIOEQUIVALENCE OF SILYMARIN PRODUCTS
    SCHULZ, HU
    SCHURER, M
    KRUMBIEGEL, G
    WACHTER, W
    WEYHENMEYER, R
    SEIDEL, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (01): : 61 - 64